{"id":32253,"date":"2026-03-15T02:15:44","date_gmt":"2026-03-15T02:15:44","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/32253\/"},"modified":"2026-03-15T02:15:44","modified_gmt":"2026-03-15T02:15:44","slug":"raymond-james-upgrades-oscar-health-inc-oscr-ubs-lowers-pt","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/32253\/","title":{"rendered":"Raymond James Upgrades Oscar Health, Inc. (OSCR), UBS Lowers PT"},"content":{"rendered":"\n

Oscar Health, Inc. (NYSE:OSCR<\/a>) is one of the best under-the-radar stocks to buy according to hedge funds<\/a>.<\/p>\n

On February 12, Raymond James upgraded its rating on Oscar Health, Inc. (NYSE:OSCR) from Market Perform to Outperform with a price target of $18 on the stock.<\/p>\n

Raymond James said the stock\u2019s valuation now looks appealing as margins across the Affordable Care Act (ACA) exchange market start to recover. The research firm noted that issues related to ACA subsidies and integrity rules appear to be largely reflected in the market, creating a more stable environment that could allow Oscar Health, Inc. (NYSE:OSCR) to modestly expand its margins in 2027.<\/p>\n

According to Raymond James, Oscar Health, Inc. (NYSE:OSCR) is the \u201cbest house in a tough neighborhood.\u201d The firm said the company\u2019s weaker Q4 results reflect past challenges and the forward-looking outlook for the company is \u201cmore supportive.\u201d<\/p>\n

The research firm expects the company to report an EBIT margin of about 2% in 2026, with expectations for it to improve to around 4% in 2027. This improvement is expected to come from lower medical costs through repricing and better administrative efficiency as the business grows.<\/p>\n

In other news, on February 11, UBS lowered its price target on Oscar Health, Inc. (NYSE:OSCR) from $17 to $15 and maintained its Neutral rating on the stock.<\/p>\n

Oscar Health, Inc. (NYSE:OSCR) is an American health insurance and healthcare technology company. Through its +Oscar platform, the company offers health insurance plans to individuals and families and health technology solutions to support the healthcare industry.<\/p>\n

While we acknowledge the potential of OSCR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you\u2019re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock<\/a>.<\/p>\n

READ NEXT: 12 Best Stocks Under $10 to Invest In Right Now<\/a> and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026<\/a>.<\/p>\n

Disclosure: None. Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Oscar Health, Inc. (NYSE:OSCR) is one of the best under-the-radar stocks to buy according to hedge funds. On…\n","protected":false},"author":2,"featured_media":32254,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[129],"tags":[18542,13316,223],"class_list":{"0":"post-32253","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ubs","8":"tag-oscar-health","9":"tag-raymond-james","10":"tag-ubs"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116230784421381534","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/32253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=32253"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/32253\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/32254"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=32253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=32253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=32253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}